ask="1.45"
ask_size="5000"
average_daily_volume="273915"
bid="1.25"
bid_size="700"
book_value="0.88"
change="+0.00"
change_from_200_day_moving_average="-1.75"
change_from_50_day_moving_average="-0.64"
change_from_52_week_high="-5.37"
change_From_52_week_low="0.05"
change_in_percent="+0.00%"
close="1.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-36.93M"
eps_estimate_current_year="-1.04"
eps_estimate_next_quarter="-0.28"
eps_estimate_next_year="-0.79"
ex_dividend_date="N/A"
float_shares="28175000"
high="1.30"
high_52_weeks="6.67"
last_trade_date="3/17/2017"
last_trade_price="1.30"
last_trade_size="8367"
last_trade_time="4:00pm"
low="1.25"
low_52_weeks="1.25"
market_capitalization="39.80M"
moving_average_200_day="3.05"
moving_average_50_day="1.94"
name="TrovaGene
Inc."
notes="N/A"
one_year_target_price="6.23"
open="1.30"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-57.34%"
percent_change_from_50_day_moving_average="-33.09%"
percent_change_from_52_week_high="-80.51%"
percent_change_from_52_week_low="+4.00%"
previous_close="1.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.49"
price_per_sales="101.49"
revenue="392168.00"
shares_outstanding="30615000"
short_ratio="15.96"
stock_exchange="NCM"
symbol="TROV"
volume="664440"
weeks_range_52="1.25 - 6.67"
